@CardioKp
FINAL REMINDER - Our next Grand Rounds presentation is this Monday, February 3rd at 2:00 PM EST! Join us as Drs. Liz Mann and Marisol Wences, PGY2 Cardiology Residents at The Ohio State University Wexner Medical Center present on genotype-guided P2Y12 inhibitor therapy in ACS!View quoted post on X
In the last decade, several disease-modifying medications are in advanced stages of clinical development or have been approved to treat ATTR-CM. OPEN ACCESS: buff.ly/424w1he @accpcardprnView quoted post on X
Scientific sessions at the 100th Anniversary of the @AHAScience in Chicago #AHA2024
Honored to Present on “Role of a Pharmacist in Outpatient Optimization of GDMT” sharing our own experience in establishing the first pharmacist led pharmacotherapy optimization clinic at @CCADView quoted post on X
Important points from @BenWangPharmD during the @HFSA focused seminar on cardiogenic shock. Ben highlighted that these patients are heterogeneous, and a tailored approach is important. @accpcardprn @ACCPView quoted post on X
Congratulations to Joshua Jacobs, 2024 New Investigator Award winner! As part of the ceremony, he will present his lecture, Gaps, Disparities, and Optimization of Pharmacotherapy in Patients with Cardiovascular Disease. #ACCPAM24
@JoshJPharmD @uofupharmacy @UofUPopHealthEdView quoted post on X
